218 related articles for article (PubMed ID: 32248805)
1. The effect of synbiotics supplementation on anthropometric indicators and lipid profiles in women with polycystic ovary syndrome: a randomized controlled trial.
Karimi E; Heshmati J; Shirzad N; Vesali S; Hosseinzadeh-Attar MJ; Moini A; Sepidarkish M
Lipids Health Dis; 2020 Apr; 19(1):60. PubMed ID: 32248805
[TBL] [Abstract][Full Text] [Related]
2. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome.
Asemi Z; Foroozanfard F; Hashemi T; Bahmani F; Jamilian M; Esmaillzadeh A
Clin Nutr; 2015 Aug; 34(4):586-92. PubMed ID: 25300649
[TBL] [Abstract][Full Text] [Related]
3. The Effects of Probiotics or Synbiotics Supplementation in Women with Polycystic Ovarian Syndrome: a Systematic Review and Meta-Analysis of Randomized Clinical Trials.
Heshmati J; Farsi F; Yosaee S; Razavi M; Rezaeinejad M; Karimie E; Sepidarkish M
Probiotics Antimicrob Proteins; 2019 Dec; 11(4):1236-1247. PubMed ID: 30547393
[TBL] [Abstract][Full Text] [Related]
4. The effect of concentrated pomegranate juice consumption on risk factors of cardiovascular diseases in women with polycystic ovary syndrome: A randomized controlled trial.
Abedini M; Ghasemi-Tehrani H; Tarrahi MJ; Amani R
Phytother Res; 2021 Jan; 35(1):442-451. PubMed ID: 32767710
[TBL] [Abstract][Full Text] [Related]
5. Effects of probiotics, prebiotics, and synbiotics on polycystic ovary syndrome: a systematic review and meta-analysis.
Li Y; Tan Y; Xia G; Shuai J
Crit Rev Food Sci Nutr; 2023; 63(4):522-538. PubMed ID: 34287081
[TBL] [Abstract][Full Text] [Related]
6. Effects of probiotic supplementation on anthropometric and metabolic characteristics in adults with metabolic syndrome: A systematic review and meta-analysis of randomized clinical trials.
Hadi A; Arab A; Khalesi S; Rafie N; Kafeshani M; Kazemi M
Clin Nutr; 2021 Jul; 40(7):4662-4673. PubMed ID: 34237694
[TBL] [Abstract][Full Text] [Related]
7. Effects of long-term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome.
Falsetti L; Pasinetti E
Acta Obstet Gynecol Scand; 1995 Jan; 74(1):56-60. PubMed ID: 7856434
[TBL] [Abstract][Full Text] [Related]
8. Metabolic response to folate supplementation in overweight women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial.
Asemi Z; Karamali M; Esmaillzadeh A
Mol Nutr Food Res; 2014 Jul; 58(7):1465-73. PubMed ID: 24828019
[TBL] [Abstract][Full Text] [Related]
9. The effects of omega-3 fatty acids and vitamin E co-supplementation on gene expression of lipoprotein(a) and oxidized low-density lipoprotein, lipid profiles and biomarkers of oxidative stress in patients with polycystic ovary syndrome.
Rahmani E; Samimi M; Ebrahimi FA; Foroozanfard F; Ahmadi S; Rahimi M; Jamilian M; Aghadavod E; Bahmani F; Taghizadeh M; Memarzadeh MR; Asemi Z
Mol Cell Endocrinol; 2017 Jan; 439():247-255. PubMed ID: 27619403
[TBL] [Abstract][Full Text] [Related]
10. The Effects of Synbiotic Supplementation on Metabolic Status in Women With Polycystic Ovary Syndrome: a Randomized Double-Blind Clinical Trial.
Samimi M; Dadkhah A; Haddad Kashani H; Tajabadi-Ebrahimi M; Seyed Hosseini E; Asemi Z
Probiotics Antimicrob Proteins; 2019 Dec; 11(4):1355-1361. PubMed ID: 29532416
[TBL] [Abstract][Full Text] [Related]
11. Beneficial effects of probiotic and synbiotic supplementation on some cardiovascular risk factors among individuals with prediabetes and type 2 diabetes mellitus: A grade-assessed systematic review, meta-analysis, and meta-regression of randomized clinical trials.
Naseri K; Saadati S; Yari Z; Asbaghi O; Hezaveh ZS; Mafi D; Hoseinian P; Ashtary-Larky D; Hekmatdoost A; de Courten B
Pharmacol Res; 2022 Aug; 182():106288. PubMed ID: 35680009
[TBL] [Abstract][Full Text] [Related]
12. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables.
Holte J; Bergh T; Berne C; Lithell H
Clin Endocrinol (Oxf); 1994 Oct; 41(4):463-71. PubMed ID: 7955457
[TBL] [Abstract][Full Text] [Related]
13. The Effects of Selenium Supplementation on Gene Expression Related to Insulin and Lipid in Infertile Polycystic Ovary Syndrome Women Candidate for In Vitro Fertilization: a Randomized, Double-Blind, Placebo-Controlled Trial.
Zadeh Modarres S; Heidar Z; Foroozanfard F; Rahmati Z; Aghadavod E; Asemi Z
Biol Trace Elem Res; 2018 Jun; 183(2):218-225. PubMed ID: 28875327
[TBL] [Abstract][Full Text] [Related]
14. The effects of vitamin D supplementation on metabolic profiles and gene expression of insulin and lipid metabolism in infertile polycystic ovary syndrome candidates for in vitro fertilization.
Dastorani M; Aghadavod E; Mirhosseini N; Foroozanfard F; Zadeh Modarres S; Amiri Siavashani M; Asemi Z
Reprod Biol Endocrinol; 2018 Oct; 16(1):94. PubMed ID: 30286768
[TBL] [Abstract][Full Text] [Related]
15. [Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome].
Roa Barrios M; Arata-Bellabarba G; Valeri L; Velázquez-Maldonado E
Endocrinol Nutr; 2009 Feb; 56(2):59-65. PubMed ID: 19627713
[TBL] [Abstract][Full Text] [Related]
16. Independent and Additive Effects of Coenzyme Q10 and Vitamin E on Cardiometabolic Outcomes and Visceral Adiposity in Women With Polycystic Ovary Syndrome.
Izadi A; Shirazi S; Taghizadeh S; Gargari BP
Arch Med Res; 2019 Feb; 50(2):1-10. PubMed ID: 31349945
[TBL] [Abstract][Full Text] [Related]
17. Clinical and psychological responses to synbiotic supplementation in obese or overweight adults: A randomized clinical trial.
Hadi A; Sepandi M; Marx W; Moradi S; Parastouei K
Complement Ther Med; 2019 Dec; 47():102216. PubMed ID: 31780038
[TBL] [Abstract][Full Text] [Related]
18. Impact of hormonal contraception and weight loss on high-density lipoprotein cholesterol efflux and lipoprotein particles in women with polycystic ovary syndrome.
Dokras A; Playford M; Kris-Etherton PM; Kunselman AR; Stetter CM; Williams NI; Gnatuk CL; Estes SJ; Sarwer DB; Allison KC; Coutifaris C; Mehta N; Legro RS
Clin Endocrinol (Oxf); 2017 May; 86(5):739-746. PubMed ID: 28199736
[TBL] [Abstract][Full Text] [Related]
19. Atherogenic lipoprotein phenotype and low-density lipoproteins size and subclasses in women with polycystic ovary syndrome.
Berneis K; Rizzo M; Lazzarini V; Fruzzetti F; Carmina E
J Clin Endocrinol Metab; 2007 Jan; 92(1):186-9. PubMed ID: 17062762
[TBL] [Abstract][Full Text] [Related]
20. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
